https://sputnikglobe.com/20210731/first-batch-of-russias-sputnik-v-covid-19-vaccine-produced-in-uzbekistan-rdif-says-1083498165.html
First Batch of Russia's Sputnik V COVID-19 Vaccine Produced in Uzbekistan, RDIF Says
First Batch of Russia's Sputnik V COVID-19 Vaccine Produced in Uzbekistan, RDIF Says
Sputnik International
MOSCOW (Sputnik) - The first test batch of Russia's Sputnik V coronavirus vaccine has been produced in Uzbekistan, with samples being shipped to Russia's... 31.07.2021, Sputnik International
2021-07-31T12:11+0000
2021-07-31T12:11+0000
2021-07-31T12:11+0000
newsfeed
world
asia
russia
coronavirus
covid-19
russia
uzbekistan
russian direct investment fund (rdif)
sputnik v vaccine
https://cdn1.img.sputnikglobe.com/img/07e5/05/09/1082841328_0:141:3141:1907_1920x0_80_0_0_5efa5e2271812813545254c55ab15e01.jpg
"The Russian Direct Investment Fund and one of the leading pharmaceutical manufacturers of Uzbekistan, Jurabek Laboratories, announce the production of the first batches of the Russian coronavirus vaccine Sputnik V. RDIF has organised a technological transfer process for the production of the vaccine in the Republic of Uzbekistan", RDIF said.Sputnik V was developed by Russia's Gamaleya research institute in August 2020, becoming the world's first registered vaccine against COVID-19. According to researchers, it shows over 91.6% efficacy against the novel coronavirus and has been authorised in 69 countries so far.
russia
uzbekistan
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rosiya Segodnya“
2021
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rosiya Segodnya“
News
en_EN
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rosiya Segodnya“
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rosiya Segodnya“
newsfeed, coronavirus, covid-19, russia, uzbekistan, russian direct investment fund (rdif), sputnik v vaccine, gamaleya research institute of epidemiology and microbiology
newsfeed, coronavirus, covid-19, russia, uzbekistan, russian direct investment fund (rdif), sputnik v vaccine, gamaleya research institute of epidemiology and microbiology
First Batch of Russia's Sputnik V COVID-19 Vaccine Produced in Uzbekistan, RDIF Says
MOSCOW (Sputnik) - The first test batch of Russia's Sputnik V coronavirus vaccine has been produced in Uzbekistan, with samples being shipped to Russia's Gamaleya research centre, which developed the vaccine, for quality control, the Russian Direct Investment Fund (RDIF) announced on Saturday.
"The Russian Direct Investment Fund and one of the leading pharmaceutical manufacturers of Uzbekistan, Jurabek Laboratories, announce the production of the first batches of the Russian coronavirus vaccine Sputnik V. RDIF has organised a technological transfer process for the production of the vaccine in the Republic of Uzbekistan", RDIF said.
"The validation batches of Sputnik V were sent to the Gamaleya research centre for the quality control," the press release added.
Sputnik V was developed by Russia's Gamaleya research institute in August 2020, becoming the
world's first registered vaccine against COVID-19. According to researchers, it shows over 91.6% efficacy against the novel coronavirus and has been authorised in 69 countries so far.
